| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d96121abcf63f7c63b0c1e3639db157c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-22 |
| filingDate |
1998-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_497c8c66792e853ca0f37b154ca39d43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da69fd81fa098f3a4a9b987a9534fba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e562f076421718a2c347915d8e222ef9 |
| publicationDate |
2000-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6063786-A |
| titleOfInvention |
Heterocyclic compounds having MMP and TNF inhibitory activity |
| abstract |
Compounds of formula (I) ##STR1## are useful as therapeutic agents, by virtue of having MMP and TNF inhibitory activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6930097-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010226922-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003199474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004122011-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2181704-A2 |
| priorityDate |
1997-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |